BioNTech SE American Depositary Share BNTX
$113.12
+21.96%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 6-K | 6-K | 2026-08-04 | View → |
| 6-K | 6-K | 2026-08-04 | View → |
| 6-K | 6-K | 2026-08-03 | View → |
| 6-K | 6-K | 2026-07-29 | View → |
| 6-K | 6-K | 2026-06-08 | View → |
| 6-K | 6-K | 2026-06-01 | View → |
| 6-K | 6-K | 2026-05-22 | View → |
| 6-K | 6-K | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-13 | View → |
| 4 | FORM 4 | 2026-05-13 | View → |
| 4 | FORM 4 | 2026-05-13 | View → |
| 4 | FORM 4 | 2026-05-13 | View → |
| 4 | FORM 4 | 2026-05-13 | View → |
| 6-K | 6-K | 2026-05-07 | View → |
| 6-K | 6-K | 2026-05-05 | View → |
| 6-K | 6-K | 2026-05-05 | View → |
| 4 | FORM 4 | 2026-04-23 | View → |
| 6-K | 6-K | 2026-04-13 | View → |
| 6-K | 6-K | 2026-04-02 | View → |
| 6-K | 6-K | 2026-03-24 | View → |
| 20-F | 20-F | 2026-03-10 | View → |
| 6-K | 6-K | 2026-03-10 | View → |
| 6-K | 6-K | 2026-03-10 | View → |
| 6-K | 6-K | 2026-01-28 | View → |
| 6-K | 6-K | 2026-01-14 | View → |
| 6-K | 6-K | 2026-01-12 | View → |
| 6-K | 6-K | 2026-01-06 | View → |
| 6-K | 6-K | 2025-12-18 | View → |
| 6-K | 6-K | 2025-12-09 | View → |
| 6-K | 6-K | 2025-12-08 | View → |
| 6-K | 6-K | 2025-12-03 | View → |
| 6-K | 6-K | 2025-11-26 | View → |
| 6-K | 6-K | 2025-11-12 | View → |
| 6-K | 6-K | 2025-11-03 | View → |
| 6-K | 6-K | 2025-11-03 | View → |
| 6-K | 6-K | 2025-10-22 | View → |
| 6-K | 6-K | 2025-10-01 | View → |
| 6-K | 6-K | 2025-09-08 | View → |
| 6-K | 6-K | 2025-09-08 | View → |
| 6-K | 6-K | 2025-09-05 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $113.12
- Market Cap
- $23.30 billion
- 52-Week Range
- $79.52 – $124.00
- Average Volume
- 1.14 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
